The nation’s third Monsanto Roundup trial is now underway in California’s Alameda County Superior Court, where a new study linking glyphosate to non-Hodgkin’s lymphoma was entered into evidence for the first time yesterday. Court Agreed to Expedite Monsanto Roundup Trial … Continue reading
The U.S. Department of Justice (DOJ) is apparently investigating Nuplazid, the controversial Parkinson’s disease treatment sold by Acadia Pharmaceuticals. DOJ Seeks Nuplazid Marketing Materials According to a recent securities filing, Acadia received a Civil Investigation Demand last September for all documents … Continue reading
A recent study suggests that more than half of all patients who receive Injectafer for iron deficiency anemia may develop severe hypophosphatemia, a potentially life-threatening condition caused by low levels of phosphorus in the blood. Injectafer and Iron Deficiency Anemia? … Continue reading
Pfizer, Inc. recently filed a Xeljanz lawsuit accusing a generic drug maker of infringing on its patents for the blockbuster rheumatoid arthritis (RA) medication. Xeljanz Lawsuit Seeks to Prevent Sales of Generic Version In February, Ajanta Pharma submitted an Abbreviated … Continue reading
Valsartan lawsuits continue to move forward in the U.S. District Court, District of New Jersey, where federal claims stemming from the ongoing generic drug recall are currently undergoing coordinated pretrial proceedings. According to a Case Management Order dated April 2nd, … Continue reading
A new clergy sexual harassment lawsuit claims the Roman Catholic Diocese of St. Cloud, Minnesota failed to address repeated complaints involving one of its priests. This is not the first time the St. Cloud Diocese has been accused of mishandling … Continue reading
Nearly three dozen people have suffered seizures after vaping, according to a new alert from the U.S. Food & Drug Administration (FDA). Although it’s not clear if there is any direct link between e-cigarettes and seizures, the agency noted that … Continue reading
A panel of advisers for the U.S. Food & Drug Administration (FDA) agreed that women should be given better information about the risks associated with breast implants, but refused to back a ban on a specific type of device that … Continue reading